Your browser doesn't support javascript.
loading
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.
Gold, Michael; Amatniek, Joan; Carrillo, Maria C; Cedarbaum, Jesse M; Hendrix, James A; Miller, Bradley B; Robillard, Julie M; Rice, J Jeremy; Soares, Holly; Tome, Maria B; Tarnanas, Ioannis; Vargas, Gabriel; Bain, Lisa J; Czaja, Sara J.
Afiliação
  • Gold M; AbbVie Inc., North Chicago, Illinois, USA.
  • Amatniek J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
  • Carrillo MC; Alzheimer's Association, Chicago, IL, USA.
  • Cedarbaum JM; Biogen, Cambridge, MA, USA.
  • Hendrix JA; Alzheimer's Association, Chicago, IL, USA.
  • Miller BB; Eli Lilly and Company, Indianapolis, IN, USA.
  • Robillard JM; Division of Neurology, Department of Medicine, University of British Columbia and Children's and Women's Hospital and Health Centres, Vancouver, BC, Canada.
  • Rice JJ; Healthcare and Life Science Research, IBM T.J. Watson Research Center, New York, NY, USA.
  • Soares H; AbbVie Inc., North Chicago, Illinois, USA.
  • Tome MB; European Medicines Agency (EMA), London, UK.
  • Tarnanas I; Altoida Inc., La Jolla, CA, USA.
  • Vargas G; Scripps Memorial Hospital, San Diego, CA, USA.
  • Bain LJ; Atlantic Fellow for Equity in Brain Health with the Global Brain Health Institute (GBHI) at UCSF, San Francisco, CA, USA.
  • Czaja SJ; Trinity College Dublin, Dublin, Ireland.
Alzheimers Dement (N Y) ; 4: 234-242, 2018.
Article em En | MEDLINE | ID: mdl-29955666

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos